This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Does route of administration affect the outcome of TNF antagonist therapy?
Arthritis Res Ther 2004, 6(Suppl 2):S19-S23 doi:10.1186/ar996
- Last 30 days: 574 accesses
- Last 365 days: 2381 accesses
- All time: 14287 accesses
These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information